The FDA has granted 510(k) clearance to Neuronetics Inc. for its obsessive-compulsive disorder motor threshold cap technology for NeuroStar Advanced Therapy for Mental Health.

Expert behavioral medicine specialists and neurologists at the WVU Rockefeller Neuroscience Institute (RNI) offer an alternative and complementary treatment option for adult patients who have major ...

Understanding mental illness requires understanding psychiatric disorder causality. New brain research explores this in ...

Transcranial magnetic stimulation pioneer Neuronetics has picked up a new FDA clearance that builds its position in obsessive-compulsive disorder (OCD), a major new application of the technology.

A new study in JAMA Psychiatry makes the case that symptom provocation may significantly improve the clinical effectiveness of repetitive transcranial magnetic stimulation (rTMS), a noninvasive ...

Transcranial magnetic stimulation, or "TMS," is an FDA-approved psychiatric treatment for major depressive disorder and obsessive-compulsive disorder (OCD), with intriguing clinical trials ...

CARY, N.C., Jan. 21, 2020 (GLOBE NEWSWIRE) -- Greenbrook TMS NeuroHealth Centers, one of the leading providers of Transcranial Magnetic Stimulation (TMS) therapy in the United States, announced ...

Transcranial magnetic stimulation sounds like — and looks like — something you'd find in a science fiction movie, but it's a real treatment option. This noninvasive therapy uses strong magnets ...

FDA generally regulates transcranial magnetic stimulation devices as class II devices, mandating certain general and specific controls to ensure patient safety. [8] Class II devices can be cleared ...

(WJAR) — Bradley Hospital is enrolling teenagers with obsessive compulsive disorder for a research study. This research involves using TMS (transcranial magnetic stimulation) to treat this ...